ma.ilunga
Submits third-party assay reports on material purchased directly. Based in Tours.
Section 1
Contribution
Purchases material, pays for assays, and submits the resulting reports to the index.
Records submitted
8
n=8
Annotations
0
n=0
Median purity submitted
98.86%
n=8
Suppliers covered
5
n=8
Section 2
Records submitted
A submitter chose to buy this material and to pay for this assay. That choice is the selection mechanism behind the whole index and it is not random.
| Report | Compound | Supplier | Lot | Lab | Quarter | Purity % | Water % | Recovery % | Provenance | Flags | Result |
|---|---|---|---|---|---|---|---|---|---|---|---|
| AX-2026-041686 | CJC-1295 (no DAC) | QSC | QSC-2606-V8637 | Janoshik | 2026-Q3 | 99.93 | 4.04 | — | Supplier-supplied | 0 | PASS |
| AX-2026-043505 | TB-500 | BCH | BCH-2509-E6436 | Janoshik | 2026-Q1 | 98.90 | 3.39 | 92.8 | Buyer-sourced | 1 | MARGINAL |
| AX-2026-042530 | Glucagon | ERP | ERP-2601-X6637 | VendorInvestigate | 2026-Q1 | 98.15 | 1.28 | — | Buyer-sourced | 0 | PASS |
| AX-2025-021030 | N-Acetyl Semax Amide | WXT | WXT-2505-J4008 | VendorInvestigate | 2025-Q4 | 97.95 | 5.50 | 93.9 | Buyer-sourced | 1 | FAIL |
| AX-2025-018876 | TB-500 | QSC | QSC-2505-B8934 | Janoshik | 2025-Q3 | 99.55 | 4.92 | — | Laboratory-retained | 1 | MARGINAL |
| AX-2025-020056 | Oxytocin | ERP | ERP-2503-A7432 | Nordanalyt | 2025-Q2 | 98.81 | 5.01 | — | Supplier-supplied | 1 | MARGINAL |
| AX-2024-005422 | GHRP-2 | WXT | WXT-2404-N4017 | Nordanalyt | 2024-Q3 | 98.58 | 5.90 | — | Supplier-supplied | 1 | FAIL |
| AX-2024-004245 | Afamelanotide | WWB | WWB-2312-P4483 | VendorInvestigate | 2024-Q1 | 99.16 | 4.32 | — | Buyer-sourced | 1 | MARGINAL |